The price of this share is at 2,12$, Indaptus Therapeutics Inc, with address at THREE COLUMBUS CIRCLE 15TH FLOOR, NEW YORK, New York, 10019, United States, is a publicly traded company and its visible heads at the moment are Jeffrey A. Meckler (Chief Executive Officer & Director), Michael James Newman (Director & Chief Scientific Officer), Nir Sassi (Chief Financial Officer), Walt A. Linscott (Chief Business Officer). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 2,18$ moving between 2,12$ and 2,23$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.